Feasibility Study: Sleuth Monitoring System
Not Applicable
- Conditions
- ArrhythmiaSyncope
- Registration Number
- NCT00719277
- Lead Sponsor
- Transoma Medical
- Brief Summary
The purpose of the study is to evaluate the safety and performance of the Sleuth Monitoring system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
-
Age > = 18 years at time of enrollment
-
Either of the following:
- MI > 30 days prior to enrolment and LVEF < = 35% by echocardiography (or nuclear imaging as necessary)
- Syncope of unknown etiology
Exclusion Criteria
- Life expectancy < 12 months following enrollment
- Active infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Diagnostically viable ECG signals daily
- Secondary Outcome Measures
Name Time Method rate of device-related adverse events 1, 6, and 12 months
Trial Locations
- Locations (1)
Hospital Paitilla
🇵🇦Panama city, Panama